Data / Form D filings / BIORELIX INC
BIORELIX INC: Form D filings
BIORELIX INC, a pharmaceuticals company in New Haven, CT, filed 5 Form D notices with the SEC between 2009 and 2012. The latest, on March 13, 2012, reports $2.6 million sold of a $2.6 million offering to 8 investors.
Find out what BIORELIX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5 SCIENCE PARK, 401 WINCHESTER AVENUE, New Haven, CT, 06511
- Phone
- (203) 785-9282
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1373982
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2012 | New notice | $2,558,096 | $2,558,096 | $0 | 8 | Mar 2, 2012 | sec.gov |
| Sep 2, 2011 | New notice | $5,310,886 | $3,644,085 | $1,666,801 | 8 | Aug 24, 2011 | sec.gov |
| Dec 22, 2010 | New notice | $4,800,000 | $2,400,000 | $2,400,000 | 7 | Dec 14, 2010 | sec.gov |
| Jan 27, 2010 | Amendment | $7,492,835 | $5,535,199 | $1,957,636 | 7 | Jul 9, 2009 | sec.gov |
| Jul 15, 2009 | New notice | $3,579,005 | $1,789,505 | $1,789,500 | 7 | Jul 9, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Philippe R. Chambon | Director | |
| Brian R. Dixon, Ph.D | Executive Officer, Director | |
| A. Donny Strosberg | Director | |
| Ronald R. Lennox | Executive Officer, Director | |
| William R. Wiesler | Director | |
| Campbell Donny Murray | Director |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Mar 12, 2012 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BIORELIX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.